Trial Profile
Ergogenic Effect of PDE-5 Inhibitors at Moderate Altitude
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Erectile dysfunction; Heart failure; Pulmonary arterial hypertension; Pulmonary hypertension
- Focus Pharmacodynamics
- 25 Oct 2018 New trial record